D.E. Speiser

Discipline

Histoire, Philosophie et Sociologie des sciences (11) Economies et finances (3)

Type de document

Articles (103) Recensions (12)

Co-auteur

Date

Source

Mot-clé

T cells (70) Patients (55) Cells (55) Patients (55) Melanoma (51) Cancer (51) Human beings (50) cancer (45) Cancer (45) Vaccination (33) Vaccination (33) Antigens (32) Immunotherapy (31) Immunotherapy (31) Receptors (30) Expression (26) Tumors (22) Treatment (21) roman (20) Tumors (19) Mice (18) différenciation (17) Differentiation (17) Blood (17) protéine (16) immunité (16) Development (16) Memory (16) Immunity (16) spectacle (15)

Documents écrit par D.E. Speiser (103) | parle de D.E. Speiser (0)

Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion.
L. Tillé et al.
CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
P. Baumgaertner et al. (10 août 2022)
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
M. Arnaud et al.
Shared acute phase traits in effector and memory human CD8 T cells.
S.A. Fuertes Marraco et al. (2022)
Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses.
A. Bovay et al. (3 août 2021)
Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.
C.B. Gilfillan et al.
Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.
J. Schaller et al. (30 mars 2021)
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.
J. Schmidt et al. (16 févr. 2021)
Not All Tumor-Infiltrating CD8+ T Cells Are Created Equal.
W. Held et al. (8 févr. 2021)
Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients.
K. de Jonge et al. (2 févr. 2021)
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.
A. Cachot et al.
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses.
M.F. Bachmann et al. (4 janv. 2021)
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
F. Berner et al. (2021)
Early drop of circulating T cells negatively correlates with the protective immune response to Yellow Fever vaccination.
A. Bovay et al. (1 déc. 2020)
Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation.
D. Pais Ferreira et al. (17 nov. 2020)
Identification of a superagonist variant of the immunodominant Yellow fever virus epitope NS4b214-222 by combinatorial peptide library screening.
A. Bovay et al.
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density.
C.B. Gilfillan et al.
Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding.
M. Spodzieja et al. (18 janv. 2020)
LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures.
N. Gestermann et al. (2020)
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid.
M. Eslami et al. (2020)
Virus-like particles for vaccination against cancer.
M.O. Mohsen et al.
Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab.
O. Blanch-Lombarte et al. (1 déc. 2019)
Defining 'T cell exhaustion'.
C.U. Blank et al.
Intratumoral CD8+ T cells with stem cell-like properties: Implications for cancer immunotherapy.
W. Held et al. (23 oct. 2019)
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells.
B. Mastelic-Gavillet et al. (10 oct. 2019)

next